GL1X · GenesisL1 explorer

MolNFT v1 · #121002 · protein

Co-crystal structure of human SMYD3 with an aza-sah compound

5HI7 · Histone-lysine N-methyltransferase SMYD3: “Co-crystal structure of human SMYD3 with an aza-sah compound”. X-ray diffraction, 3 ligands (62X, ZN, MG), 1 pocket (best druggability 0.81). MolNFT v1 #121002 on GenesisL1: 3D structure…

PDB
5HI7
Type
protein
Length
426 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SMYD3
EC
2.1.1.43
UniProt
Q9H7B4
Ligands
62X, ZN, MG
Pockets
1 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43)protein42650% helix, 13% strandQ9H7B4

Ligands and binding sites

  • 62X · 5'-{[(3S)-3-amino-3-carboxypropyl][3-(dimethylamino) propyl]amino}-5'-deoxyadenosine · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A
  • MG · Magnesium ion · metal · 2 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110050.810.82107MG, DMS, 62X

Compared structures

  • Q9H7B4 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase SMYD3 (Q9H7B4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.